Failure to Provide Timely Post-Surgical Pain Management
Penalty
Summary
A deficiency occurred when a resident who had recently undergone a below-the-knee amputation was not provided with adequate post-surgical pain management. The resident had a physician's order for Oxycodone 10 mg every four hours as needed for moderate pain, and acetaminophen scheduled every eight hours. The resident consistently reported significant pain, with pain levels ranging from 7 to 10, and had received 17 doses of Oxycodone prior to the incident. The care plan identified the resident as being at risk for pain due to the recent surgical procedure, with interventions including medication and repositioning. On the night of the incident, the resident experienced severe pain rated at 10 out of 10 and requested narcotic pain medication. However, the Oxycodone prescription had expired and was not renewed in a timely manner, resulting in no narcotic pain medication being available. The on-call nurse practitioner declined to renew the prescription during the night and instead ordered extra strength Tylenol, which the resident refused. As a result, the resident requested transfer to the hospital for pain management and was subsequently transported by EMS. Interviews with staff confirmed that the failure to renew the Oxycodone prescription led to the unavailability of the medication when the resident was in severe pain. The DON acknowledged that the prescription had expired and was not renewed, which directly resulted in the resident's transfer to the hospital for pain control. The facility's pain management policy defined pain management as alleviating pain to a level acceptable to the resident, but this standard was not met in this case.
Plan Of Correction
This Plan of Correction is being prepared and executed because it is required by the provisions of the State and Federal regulations and not because Kingston of Ashland agrees with the allegations and citations listed on the statement of deficiencies. Kingston of Ashland maintains that the alleged deficiencies do not individually or collectively jeopardize the health and safety of the residents, nor are they of such character as to limit our capacity to render adequate care as prescribed by regulation. This plan of correction shall operate as Kingston of Ashland's written credible allegations of compliance. This plan of correction is not meant to establish any standard of care, contract, obligation, or position, and Kingston of Ashland reserves all possible contentions and defenses in any civil or criminal actions or proceeding. Please accept the date of correction 4/17/2025 as the facility's credible allegation of compliance. F697 Resident #93 no longer resides in the center. Resident #93 was sent to the ER on 3/7 and script for Percocet obtained at that time. Nurse practitioner #339 was provided education on 4/3 and 4/4 on the pain assessment and management policy, controlled substance prescription policy, and receiving controlled substances policy. The Director of Nursing or designee will review current residents on narcotic pain medications to ensure that the narcotic medication regimen is effective for treating pain and that the narcotic pain medications are available for use. This will be completed on or before 4/17/2025. Issues identified will be addressed at the time of discovery. The Director of Nursing or designee will educate licensed nurses and Certified Medication Aides on the controlled substance prescription policy and receiving controlled substance policy, which includes reordering of controlled medications, on or before 4/17/2025. The Director of Nursing or designee with educated licensed nurses on the pain assessment and management policy on or before 4/17/2025. The Director of Advanced Nurse Practitioners will educate the nurse practitioners on the controlled substance prescription policy and receiving controlled substance policy, which includes reordering of controlled medications, on or before 4/17/2025. The Director of Nursing or designee will complete an audit on 5 residents weekly for 4 weeks that receive narcotic pain medications to ensure that the narcotic medication regimen is effective for treating pain and that narcotic pain medication is available for use. The results will be presented to the QAA committee for review and consideration for further corrective actions.